CEL and cancer: The scFv (or mAb) of cilta-cel is responsible for human leukocyte antigen (HLA)-independent binding to a BCMA expressed on the surface of the cancer cell, leading to the activation of downward signaling proteins, including CD3ζ and CMs, within the CAR T-cell.